Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial function
Standard
Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial function. / Schuster, Christopher; Binder, Christina; Strassl, Robert; Aichelburg, Maximilian C; Blackwell, Emma; Pavo, Noemi; Ramharter, Michael; Hülsmann, Martin; Grabmeier-Pfistershammer, Katharina; Rieger, Armin; Goliasch, Georg.
In: AIDS, Vol. 31, No. 3, 28.01.2017, p. 395-400.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial function
AU - Schuster, Christopher
AU - Binder, Christina
AU - Strassl, Robert
AU - Aichelburg, Maximilian C
AU - Blackwell, Emma
AU - Pavo, Noemi
AU - Ramharter, Michael
AU - Hülsmann, Martin
AU - Grabmeier-Pfistershammer, Katharina
AU - Rieger, Armin
AU - Goliasch, Georg
PY - 2017/1/28
Y1 - 2017/1/28
N2 - OBJECTIVE: Vasoactive cardiovascular hormones such as the N-terminal prohormone of brain natriuretic peptide (NT-proBNP) are produced upon ventricular stretch and play a central role in neurohumoral pathways of the heart regulating cardiovascular remodeling and volume homeostasis. The impact of HIV infection on these neurohumoral pathways of the heart and its potential reversibility by combinations of antiretroviral therapies remain unclear.METHODS: We assessed serum levels of NT-proBNP in 219 antiretroviral therapy-naïve HIV-infected patients with a normal cardiac and renal status at treatment initiation and after attainment of viremic control.RESULTS: Before antiretroviral therapy, NT-proBNP as a surrogate of myocardial function displayed a significant correlation with absolute CD4 cell count (r = -0.31; P < 0.001) as well as with HIV viral load (r = 0.26; P < 0.001). The median levels of NT-proBNP were 80 pg/ml (36-205) in patients with a CD4 cell count less than 200 cells/μl and 42 pg/ml (20-80; P < 0.001) with a CD4 cell count more than 500 cells/μl. After viremic control, no statistical correlation was present.CONCLUSION: Higher NT-proBNP levels were observed in treatment-naïve patients with low CD4 cell count and high HIV viral load, indicating a subclinical impact of HIV infection on myocardial function. This association is reversible by the initiation of antiretroviral therapy and subsequent viral suppression.
AB - OBJECTIVE: Vasoactive cardiovascular hormones such as the N-terminal prohormone of brain natriuretic peptide (NT-proBNP) are produced upon ventricular stretch and play a central role in neurohumoral pathways of the heart regulating cardiovascular remodeling and volume homeostasis. The impact of HIV infection on these neurohumoral pathways of the heart and its potential reversibility by combinations of antiretroviral therapies remain unclear.METHODS: We assessed serum levels of NT-proBNP in 219 antiretroviral therapy-naïve HIV-infected patients with a normal cardiac and renal status at treatment initiation and after attainment of viremic control.RESULTS: Before antiretroviral therapy, NT-proBNP as a surrogate of myocardial function displayed a significant correlation with absolute CD4 cell count (r = -0.31; P < 0.001) as well as with HIV viral load (r = 0.26; P < 0.001). The median levels of NT-proBNP were 80 pg/ml (36-205) in patients with a CD4 cell count less than 200 cells/μl and 42 pg/ml (20-80; P < 0.001) with a CD4 cell count more than 500 cells/μl. After viremic control, no statistical correlation was present.CONCLUSION: Higher NT-proBNP levels were observed in treatment-naïve patients with low CD4 cell count and high HIV viral load, indicating a subclinical impact of HIV infection on myocardial function. This association is reversible by the initiation of antiretroviral therapy and subsequent viral suppression.
KW - Adult
KW - Anti-Retroviral Agents/therapeutic use
KW - Biomarkers/blood
KW - CD4 Lymphocyte Count
KW - Cardiomyopathies/diagnosis
KW - Female
KW - HIV Infections/complications
KW - Humans
KW - Male
KW - Middle Aged
KW - Natriuretic Peptide, Brain/blood
KW - Peptide Fragments/blood
KW - Viral Load
U2 - 10.1097/QAD.0000000000001350
DO - 10.1097/QAD.0000000000001350
M3 - SCORING: Journal article
C2 - 28081038
VL - 31
SP - 395
EP - 400
JO - AIDS
JF - AIDS
SN - 0269-9370
IS - 3
ER -